| A prophylactic α-Gal-based glycovaccine effectively protects against murine acute Chagas disease S Portillo, BG Zepeda, E Iniguez, JJ Olivas, NH Karimi, OC Moreira, ... Npj Vaccines 4 (1), 13, 2019 | 65 | 2019 |
| A prophylactic alpha-Galbased glycovaccine effectively protects against murine acute Chagas disease. NPJ Vaccines. 2019; 4: 13 S Portillo, BG Zepeda, E Iniguez, JJ Olivas, NH Karimi, OC Moreira, ... DOI, 0 | 65 | |
| Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of α-Gal-Containing Neoglycoproteins … U Ortega-Rodriguez, S Portillo, RA Ashmus, JA Duran, NS Schocker, ... T. cruzi Infection: Methods and Protocols, 287-308, 2019 | 22 | 2019 |
| The fibrinolytic system enables the onset of Plasmodium infection in the mosquito vector and the mammalian host TL Alves e Silva, A Radtke, A Balaban, TV Pascini, ZR Pala, A Roth, ... Science advances 7 (6), eabe3362, 2021 | 19 | 2021 |
| The 20-hydroxyecdysone agonist, halofenozide, promotes anti-Plasmodium immunity in Anopheles gambiae via the ecdysone receptor RA Reynolds, H Kwon, TL Alves e Silva, J Olivas, J Vega-Rodriguez, ... Scientific Reports 10 (1), 1-9, 2020 | 9 | 2020 |
| Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteins SM Viana, AL Montoya, AM Carvalho, BS de Mendonça, S Portillo, ... Emerging Microbes & Infections 11 (1), 2147-2159, 2022 | 5 | 2022 |
